Useful Resources
Surveys
Take part in our surveys!
EANM surveys
Please share your valuable input with us by taking part in the surveys listed below.
Role of nuclear medicine technologist in theranostics / clinical trials survey
15
As part of the international collaborative initiative gathering the ANZSNM Theranostics Special Interest Group (ANZSNM-TSIG), the International Atomic Energy Agency (IAEA), the SNMMI Technologist Section (SNMMI-TS) and the EANM Technologists Committee (EANM-TC), we invite all Nuclear Medicine Technologists to participate in the Role of Nuclear Medicine Technologist in Theranostics / Clinical Trials Survey.
The goal of this survey is to investigate, evaluate, and establish recommendations for Nuclear Medicine Technologist (NMT) education, training, and professional competency standards in the field of Theranostics. Your input will directly contribute to the development of evidence-based consensus recommendations, best practice articles, and future guidelines that will harmonise global standards while recognising country-specific practices.
⏰ Please participate before December 15, and share it with colleagues! It will take you only 10 minutes to complete.
Clinical Trials Survey
31
The EANM Policy Project Group on ACT EU and Clinical Trials invites professionals with experience in clinical research to participate in a short survey (15 questions).
This initiative supports the Accelerating Clinical Trials in the EU (ACT EU) programme, led by the European Commission, EMA and HMA, which aims to modernise and streamline clinical research across Europe.
The survey seeks to identify key challenges, gaps and opportunities for academic and non-commercial sponsors in nuclear medicine, helping to shape EANM’s positioning and contributions to ACT EU and the Reducing Bureaucracy in Clinical Trials Coalition.
⏰ Please participate before December 31, and share it with colleagues! It will take you only 10 minutes to complete.
Surveys supported by EANM
Please share your valuable input on the following initiatives by participating in the surveys listed below.
SCAN 2025 Global Survey on access to diagnostics, treatments and care for NET patients worldwide
30
The International Neuroendocrine Cancer Alliance (INCA) coordinates NET Cancer Day on November 10, to raise awareness on neuroendocrine cancers (NETs). This year, INCA invites NET patients, caregivers and healthcare professionals to take part in the SCAN 2025 Global Survey on Challenges in Access to Diagnostics, Treatments and Care for NET Patients.
The survey aims to gather global insights on NET diagnostics, treatments and care, building on the findings of SCAN 2019, the largest NET data collection to date.
The survey is open until November 30, 2025 and is available in 15 languages.
Joint EFOMP/ESTRO/ESR/EANM survey on in-house software in medical physics
15
The Joint EFOMP/ESTRO/ESR/EANM Working Group Software as a Medical Device in Medical Physics invites professionals involved in medical physics software to take part in a new European survey. The goal is to capture current in-house software development practices and understand how the EU MDR 2017–745 has impacted them.
The survey targets medical physicists, engineers, and IT experts across clinical, academic, regulatory, and industry settings who develop, use, or evaluate in-house software. Multiple responses per institution are welcome, so please share with colleagues.
The survey is open until December 15, 2025.
